We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oscar Health Inc | NYSE:OSCR | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.19 | 1.15% | 16.66 | 17.56 | 16.31 | 16.53 | 3,255,239 | 01:00:00 |
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025.
Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows:
Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following February 4, 2025 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.65 million members, as of September 30, 2024.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250109337618/en/
Investor: Chris Potochar VP of Investor Relations ir@hioscar.com
Media: Kristen Prestano VP of Communications press@hioscar.com
1 Year Oscar Health Chart |
1 Month Oscar Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions